3.58
Precedente Chiudi:
$3.84
Aprire:
$3.79
Volume 24 ore:
371.58K
Relative Volume:
0.47
Capitalizzazione di mercato:
$269.61M
Reddito:
$299.48M
Utile/perdita netta:
$-86.45M
Rapporto P/E:
-2.3867
EPS:
-1.5
Flusso di cassa netto:
$-17.32M
1 W Prestazione:
-6.77%
1M Prestazione:
-18.82%
6M Prestazione:
-58.37%
1 anno Prestazione:
-35.84%
Health Catalyst Inc Stock (HCAT) Company Profile
Nome
Health Catalyst Inc
Settore
Industria
Telefono
801-708-6800
Indirizzo
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Confronta HCAT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
HCAT
Health Catalyst Inc
|
3.58 | 269.61M | 299.48M | -86.45M | -17.32M | -1.50 |
![]()
VEEV
Veeva Systems Inc
|
210.08 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
51.28 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
40.98 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
80.20 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.21 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
2025-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2024-04-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2024-01-03 | Iniziato | Barclays | Overweight |
2024-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-12-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-11-13 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-08-01 | Iniziato | Cantor Fitzgerald | Overweight |
2023-05-10 | Downgrade | Guggenheim | Buy → Neutral |
2023-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-04-20 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-04-12 | Iniziato | Stephens | Equal-Weight |
2023-04-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
2022-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-13 | Downgrade | Piper Sandler | Overweight → Neutral |
2022-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
2022-08-05 | Downgrade | Stifel | Buy → Hold |
2022-04-14 | Iniziato | Guggenheim | Buy |
2022-03-17 | Aggiornamento | Jefferies | Hold → Buy |
2022-02-11 | Iniziato | Goldman | Buy |
2021-12-02 | Iniziato | Jefferies | Hold |
2021-10-14 | Iniziato | BTIG Research | Buy |
2021-04-29 | Ripresa | JP Morgan | Overweight |
2020-12-08 | Iniziato | Berenberg | Buy |
2020-07-14 | Iniziato | Citigroup | Buy |
2020-06-18 | Iniziato | Stifel | Buy |
2020-06-15 | Ripresa | Evercore ISI | Outperform |
2020-05-15 | Iniziato | Guggenheim | Buy |
2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
2020-04-13 | Iniziato | SVB Leerink | Outperform |
2020-04-02 | Iniziato | Canaccord Genuity | Buy |
2019-12-20 | Iniziato | Raymond James | Strong Buy |
2019-10-30 | Iniziato | Cantor Fitzgerald | Overweight |
2019-08-19 | Iniziato | Evercore ISI | Outperform |
2019-08-19 | Iniziato | Goldman | Buy |
2019-08-19 | Iniziato | JP Morgan | Overweight |
2019-08-19 | Iniziato | Piper Jaffray | Overweight |
2019-08-19 | Iniziato | SVB Leerink | Outperform |
2019-08-19 | Iniziato | SunTrust | Buy |
2019-08-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Health Catalyst Inc Borsa (HCAT) Ultime notizie
Best Statistical Healthcare Cognitive Analytics Market Growth - openPR.com
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 - The Manila Times
Healthcare Analytics Leader Health Catalyst Sets Q1 2025 Earnings Release Date - Stock Titan
Health Catalyst stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
Health Catalyst stock hits 52-week low at $3.56 amid market challenges - Investing.com India
KeyBanc Adjusts Price Target for Health Catalyst (HCAT) Ahead of Q1 Earnings | HCAT Stock News - GuruFocus
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock - Investing.com
Healthcare Data Analytics Market Is Booming Worldwide 2025-2032 | Health Catalyst, Oracle, Optum, SAS - openPR.com
HIMSSCast: "How do we grow again?" - Healthcare Finance News
Health Catalyst launches data and analytics solution for healthcare organisations - Yahoo Finance
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 - Yahoo Finance
Health Catalyst Releases Data and Analytics Solution Designed fo - GuruFocus
Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™ - PR Newswire
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Forecasting The Future: 10 Analyst Projections For Health Catalyst - Benzinga
Evercore ISI cuts Health Catalyst stock rating to In Line By Investing.com - Investing.com India
Evercore ISI cuts Health Catalyst stock rating to In Line - Investing.com
Health Catalyst COO Daniel LeSueur sells shares worth $21,604 By Investing.com - Investing.com South Africa
Health Catalyst COO Daniel LeSueur sells shares worth $21,604 - Investing.com Australia
Health Catalyst stock hits 52-week low at $3.75 amid market challenges - Investing.com India
Health Catalyst stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa
Institutional investors may adopt severe steps after Health Catalyst, Inc.'s (NASDAQ:HCAT) latest 10.0% drop adds to a year losses - simplywall.st
Personalized healthcare: Resolving the payer-provider conflict for better patient outcomes - Modern Healthcare
5 leading hospital chargemaster software products - TechTarget
Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook - Seeking Alpha
Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock? - TradingView
Healthcare Predictive Analytics Market Set to Witness - openPR
Health Catalyst stock rating reiterated at William Blair - Investing.com
Health Catalyst stock rating reiterated at William Blair By Investing.com - Investing.com Australia
Predictive Disease Analytics Market Top Players- SAS; - openPR
Health Catalyst repurchases $5M worth of shares - MSN
Health Catalyst buys back $5 million in stock By Investing.com - Investing.com Australia
Health Catalyst Expands Buyback With $5 Mln Share Repurchase - Nasdaq
Health Catalyst to buy back shares worth about $5 mln -March 11, 2025 at 10:37 am EDT - Marketscreener.com
Health Catalyst Repurchases $5 Million in Common Stock -March 11, 2025 at 10:20 am EDT - Marketscreener.com
Health Catalyst Announces ~$5 Million Stock Repurchase - Quantisnow
Health Catalyst buys back $5 million in stock - Investing.com
Health Catalyst COO Daniel LeSueur sells $76,331 in stock By Investing.com - Investing.com Australia
Health Catalyst general counsel Landry Benjamin sells $62,860 in stock By Investing.com - Investing.com Canada
Health Catalyst general counsel Landry sells shares worth $62,860 - Investing.com
Health Catalyst general counsel Landry sells shares worth $62,860 By Investing.com - Investing.com Canada
Health Catalyst general counsel Landry Benjamin sells $62,860 in stock - Investing.com
Health Catalyst COO Daniel LeSueur sells $76,331 in stock - Investing.com India
Health Catalyst Inc Azioni (HCAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):